RecruitingPhase 2NCT02747303

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

The Clinical Relevance of Margins in Frameless Stereotactic Radiosurgery for Intact Brain Metastases: a Randomized Trial of 0 vs 2 mm Margins


Sponsor

University of Chicago

Enrollment

166 participants

Start Date

Sep 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This is a randomized study to determine if not treating planning target volume (PTV) margins during radiation therapy worsens progression free survival rates in patients with brain metastases.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing frameless stereotactic radiosurgery — a highly precise, non-invasive radiation treatment that delivers focused beams directly to brain tumors — for patients whose cancer has spread to the brain from another part of the body. **You may be eligible if...** - You are 18 or older with a life expectancy of at least 3 months - You have 1 to 5 brain tumors confirmed by MRI that spread from a cancer elsewhere in your body - Each brain tumor is no larger than 3 cm (about 1.2 inches) in diameter - At least one tumor is large enough to be measured (at least 1 cm across) - Women of childbearing age must have a negative pregnancy test before the CT planning scan **You may NOT be eligible if...** - You have more than 5 brain tumors - Any tumor is larger than 3 cm in diameter - You have cancer spread along the fluid surrounding the brain (leptomeningeal disease) - You are pregnant - You are not well enough to complete treatment and follow-up appointments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREStereotactic Radiosurgery

The SRS dose will depend on the maximum diameter of the gross tumor volume (GTV)


Locations(1)

University of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02747303


Related Trials